Nivolumab
(asked on 3rd June 2015) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty’s Government what plans they have to improve lung cancer therapy available on the NHS in the light of the recent trial of Nivolumab.
This question was answered on 16th June 2015
Nivolumab for previously treated locally advanced or metastatic non-small cell lung cancer was referred to the National Institute for Care Excellence (NICE) in March 2015. The development of the appraisal is expected to start shortly, and NICE is anticipating final guidance to be issued in May 2016.